Recombinant protein (or fragment).This information is considered to be commercially sensitive.
Conjugation:
ABflo 647
Alternative Names:
KAL1, NTBA, KAL1b, Ly108, NTB-A, SF2000
SLAMF6 (CD352/NTB-A) is a type I transmembrane glycoprotein belonging to the signaling lymphocyte activation molecule (SLAM) family of immunoregulatory receptors. Like other members of the SLAM receptor family, SLAMF6 possesses an extracellular region containing immunoglobulin (Ig)-like domains and an intracellular domain harboring conserved tyrosine-based signaling motifs. Upon phosphorylation, these motifs recruit the SAP (SLAM-associated protein) and EAT-2 adaptor signaling molecules. SLAMF6 is expressed on the surface of multiple immune cell lineages, including B cells, T cells, and natural killer (NK) cells. Its activation is triggered by homophilic interactions mediated through its extracellular domain. Functional studies demonstrate that SLAMF6 engagement in T cells promotes cellular activation and cytokine production. Similarly, ligand-induced homotypic binding of SLAMF6 in NK cells initiates signaling cascades that enhance proliferation, cytotoxic activity, and cytokine secretion.
Cross-Reactivity: Mouse. ResearchArea: Immunology Cell Type Markers CD NK Cells. Shipping: Ice Bag
Flow cytometry: 1X10 6 C57BL/6 mouse splenocytes were surface-stained with FITC anti-Mouse/Human CD45R/B220 mAb (A25655,5 µl/Test) and ABflo 647 Rabbit IgG isotype control (A22070,5 µl/Test,left) or ABflo 647 Rabbit anti-Mouse CD352/SLAMF6 mAb (A27923,0.5 µg,right).
* VAT and and shipping costs not included. Errors and price changes excepted
